Last reviewed · How we verify
Reslizumab IV
Reslizumab IV is a Small molecule drug developed by Teva Branded Pharmaceutical Products R&D, Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | Reslizumab IV |
|---|---|
| Sponsor | Teva Branded Pharmaceutical Products R&D, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists (PHASE1)
- Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma (PHASE4)
- Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis (PHASE2)
- A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma (PHASE3)
- A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma (PHASE3)
- An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation (PHASE4)
- Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma (PHASE2, PHASE3)
- Effect of Reslizumab in Chronic Rhinosinusitis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Reslizumab IV CI brief — competitive landscape report
- Reslizumab IV updates RSS · CI watch RSS
- Teva Branded Pharmaceutical Products R&D, Inc. portfolio CI
Frequently asked questions about Reslizumab IV
What is Reslizumab IV?
Reslizumab IV is a Small molecule drug developed by Teva Branded Pharmaceutical Products R&D, Inc..
Who makes Reslizumab IV?
Reslizumab IV is developed by Teva Branded Pharmaceutical Products R&D, Inc. (see full Teva Branded Pharmaceutical Products R&D, Inc. pipeline at /company/teva-branded-pharmaceutical-products-r-d-inc).
What development phase is Reslizumab IV in?
Reslizumab IV is in Phase 1.
Related
- Manufacturer: Teva Branded Pharmaceutical Products R&D, Inc. — full pipeline
- Compare: Reslizumab IV vs similar drugs
- Pricing: Reslizumab IV cost, discount & access